Caribou Biosciences(us:CRBU)

0.8411

-7.89%

Updated on 2025-04-02

Open:0.9377
Close:0.8411
High:0.9377
Low:0.8363
Prev Close:0.9131
Volume:808256.00
Turnover:705996.50
Turnover Ratio:0.87%
Shares:93.00M
MarketCap:78.23M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-301685304408758.70%254076
2024-03-311666643935473.56%284265
2023-12-311536878563077.77%305345
2023-09-301417056734879.80%265639
2023-06-301414368919466.10%204351
2023-03-311394485403873.14%134950
2022-12-311404357592871.40%293648
2022-09-301324297059370.46%134947
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Blackrock Inc.70050627.76%-63406-0.90%
2024-03-31Pfm Health Sciences, Lp64832707.18%25060.04%
2024-03-31State Street Corp63473217.03%122765523.98%
2024-03-31Avidity Partners Management Lp57853526.41%-574860-9.04%
2024-03-31Vanguard Group Inc41107954.55%1487513.75%
2024-03-31Point72 Asset Management, L.P.35850183.97%636421.81%
2024-03-31Alkeon Capital Management Llc27435053.04%-370059-11.88%
2024-03-31Elmwood Wealth Management, Inc.23642402.62%-20-0.00%
2024-03-31Paradigm Biocapital Advisors Lp21726202.41%-751231-25.69%
2024-03-31Dimensional Fund Advisors Lp20871212.31%73633754.51%

About

Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
Address:2929 7th Street,Suite 105

Market Movers